Who Paid My Doc
Research studies in the Open Payments record
139,921 studies have research funding reported against them. Being named on a study as a principal investigator is reported separately from being paid.
Studies
50 of 139,921- M14-682 - Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis No ClinicalTrials.gov identifier reported
- M14-702 NCT03213457
- M14-702 - A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated Pain No ClinicalTrials.gov identifier reported
- M14-728 NCT02966756
- M14-748 NCT02486406
- M14867-32 No ClinicalTrials.gov identifier reported
- M15-340 NCT03725007
- M15-340 - A Study to Evaluate the Pharmacokinetics Safety and Tolerability of Upadacitinib in Pediatric Subjects With Polyarticular Course Juvenile Idiopathic Arthritis No ClinicalTrials.gov identifier reported
- M15-394 NCT02565758
- M15-522 NCT02966782
- M15-531 NCT02942290
- M15-531 - A Study Evaluating Venetoclax in Combination With Azacitidine in Participants With Treatment- Higher-Risk Myelodysplastic Syndromes (MDS) No ClinicalTrials.gov identifier reported
- M15-534 NCT02944396
- M15-535 NCT02799381
- M15-538 NCT02899052
- M15-538 - Study of Venetoclax in Combination With Carfilzomib and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma (MM) No ClinicalTrials.gov identifier reported
- M15-550 NCT02756611
- M15-554 NCT03104374
- M15-555 NCT02706951
- M15-562 NCT02985879
- M15-563 NCT03391765
- M15-566 No ClinicalTrials.gov identifier reported
- M15-566 NCT02880956
- M15-570 NCT03712787
- M15-572 NCT03104400
- M15-572 - A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug (DMARD) No ClinicalTrials.gov identifier reported
- M15-574 NCT02808975
- M15-654 NCT03314181
- M15-654 - A Study of Combination Therapy With Venetoclax Daratumumab and Dexamethasone (With and Without Bortezomib) in Participants With Relapsed or Refractory Multiple Myeloma No ClinicalTrials.gov identifier reported
- M15-656 NCT02993523
- M15-722 NCT03695185
- M15-736 NCT04380142
- M15-737 NCT04379050
- M15-737 ABBV-951 Ph 3 Open Label Extension Study (Ind 1) NCT04379050
- M15-737 - Extension Study To Evaluate Safety And Tolerability Of 24-Hour Daily Exposure Of Continuous Subcutaneous Infusion of ABBV-951 In Adult Participants With Parkinson Disease No ClinicalTrials.gov identifier reported
- M15-738 NCT03033498
- M15-739 NCT03374917
- M15-741 NCT03781167
- M15-741 No ClinicalTrials.gov identifier reported
- M15-819 NCT02955251
- M15-862 NCT02988960
- M15-889 NCT02980731
- M15-891 NCT03000257
- M15-913 NCT03082209
- M15-916 NCT03145909
- M15-925 NCT03086343
- M15-942 NCT02939989
- M15-954 NCT04401748
- M15-954 - Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome No ClinicalTrials.gov identifier reported
- M15-989 NCT02513459